136 related articles for article (PubMed ID: 19412673)
1. Preoperative serum leptin levels in patients with breast cancer.
Aliustaoglu M; Bilici A; Gumus M; Colak AT; Baloglu G; Irmak R; Seker M; Ustaalioglu BB; Salman T; Sonmez B; Salepci T; Yaylaci M
Med Oncol; 2010 Jun; 27(2):388-91. PubMed ID: 19412673
[TBL] [Abstract][Full Text] [Related]
2. Tissue leptin levels in patients with breast cancer.
Karaduman M; Bilici A; Ozet A; Sengul A; Musabak U; Alomeroglu M
J BUON; 2010; 15(2):369-72. PubMed ID: 20658737
[TBL] [Abstract][Full Text] [Related]
3. Combination of Endogenous Estradiol and Adipokine Leptin in Breast Cancer Risk and Prognosis Assessment in Postmenopausal Chinese Women.
Luo Y; Li HB; Zhang Y; Wu YX; Shen D; Che YQ
Front Endocrinol (Lausanne); 2021; 12():766463. PubMed ID: 34970222
[TBL] [Abstract][Full Text] [Related]
4. Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications.
Macciò A; Madeddu C; Gramignano G; Mulas C; Floris C; Massa D; Astara G; Chessa P; Mantovani G
J Mol Med (Berl); 2010 Jul; 88(7):677-86. PubMed ID: 20339829
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
[TBL] [Abstract][Full Text] [Related]
6. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer.
Sauter ER; Garofalo C; Hewett J; Hewett JE; Morelli C; Surmacz E
Horm Metab Res; 2004 May; 36(5):336-40. PubMed ID: 15156414
[TBL] [Abstract][Full Text] [Related]
7. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
8. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
Assiri AM; Kamel HF; Hassanien MF
Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
[TBL] [Abstract][Full Text] [Related]
9. SERUM LEPTIN LEVEL IN BREAST CANCER.
Koprivčić I; Marjanović K; Matić A; Tolušić Levak M; Lovrić I; Pauzar B; Erić I; Wertheimer V
Acta Clin Croat; 2022 Mar; 61(1):79-85. PubMed ID: 36398078
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancer.
Assiri AM; Kamel HF
Obes Res Clin Pract; 2016; 10(4):442-53. PubMed ID: 26388139
[TBL] [Abstract][Full Text] [Related]
11. Serum resistin is inversely related to breast cancer risk in premenopausal women.
Georgiou GP; Provatopoulou X; Kalogera E; Siasos G; Menenakos E; Zografos GC; Gounaris A
Breast; 2016 Oct; 29():163-9. PubMed ID: 27521488
[TBL] [Abstract][Full Text] [Related]
12. Effects of tamoxifen on the serum leptin level in patients with breast cancer.
Ozet A; Arpaci F; Yilmaz MI; Ayta H; Ozturk B; Komurcu S; Yavuz AA; Tezcan Y; Acikel C
Jpn J Clin Oncol; 2001 Sep; 31(9):424-7. PubMed ID: 11689595
[TBL] [Abstract][Full Text] [Related]
13. Serum adiponectin but not leptin at diagnosis as a predictor of breast cancer survival.
Lee SA; Sung H; Han W; Noh DY; Ahn SH; Kang D
Asian Pac J Cancer Prev; 2014; 15(15):6137-43. PubMed ID: 25124587
[TBL] [Abstract][Full Text] [Related]
14. Serum adiponectin and leptin levels in Taiwanese breast cancer patients.
Chen DC; Chung YF; Yeh YT; Chaung HC; Kuo FC; Fu OY; Chen HY; Hou MF; Yuan SS
Cancer Lett; 2006 Jun; 237(1):109-14. PubMed ID: 16019138
[TBL] [Abstract][Full Text] [Related]
15. Serum leptin in overt and subclinical hypothyroidism: effect of levothyroxine treatment and relationship to menopausal status and body composition.
Teixeira PF; Cabral MD; Silva NA; Soares DV; Braulio VB; Couto AP; Henriques JL; Costa AJ; Buescu A; Vaisman M
Thyroid; 2009 May; 19(5):443-50. PubMed ID: 19415994
[TBL] [Abstract][Full Text] [Related]
16. Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics.
Provatopoulou X; Georgiou GP; Kalogera E; Kalles V; Matiatou MA; Papapanagiotou I; Sagkriotis A; Zografos GC; Gounaris A
BMC Cancer; 2015 Nov; 15():898. PubMed ID: 26560078
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of leptin, insulin, and lipids in relation to breast cancer in china.
Han C; Zhang HT; Du L; Liu X; Jing J; Zhao X; Yang X; Tian B
Endocrine; 2005 Feb; 26(1):19-24. PubMed ID: 15805581
[TBL] [Abstract][Full Text] [Related]
18. The relationship between breast cancer treatment, tumour type and vitamin D level in pre- and postmenopausal women.
Streb J; Glanowska I; Streb A; Szpor J; Kryka K; Potocki P; Wójcik M; Jach R
Neuro Endocrinol Lett; 2017 Dec; 38(6):437-440. PubMed ID: 29298285
[TBL] [Abstract][Full Text] [Related]
19. [Association of plasma leptin levels and soluble leptin receptor with breast cancer].
Yi F; Diao S; Yuan XL; Li JY
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):253-259. PubMed ID: 29973003
[No Abstract] [Full Text] [Related]
20. Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort.
Agnoli C; Grioni S; Pala V; Allione A; Matullo G; Gaetano CD; Tagliabue G; Sieri S; Krogh V
Sci Rep; 2017 Oct; 7(1):12708. PubMed ID: 28983080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
